Literature DB >> 17337910

Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury.

Ihab M Mahmoud1, Abd El-Aziz M Hussein, Mohammed E Sarhan, Ali A Awad, Ibrahim El Desoky.   

Abstract

BACKGROUND: L-Arginine (L-arg) and Prostaglandin E(1) (PGE(1)) have been used effectively as single agents to ameliorate renal ischemia-reperfusion injury. We hypothesized that combined treatment with L-arg and PGE(1 )would be more effective.
MATERIALS AND METHODS: The left renal artery of male Sprague-Dawley rats was clamped for 45 min and the right kidney was removed. Fifty six rats were randomly allocated into 5 groups each consisted of 12 rats except sham group (n = 8). (1) sham, underwent right nephrectomy only; (2) control, untreated ischemic rats; (3) L-arg group, L-arg-treated ischemic rats; (4) PGE(1) group, PGE(1)-treated ischemic rats; (5) L-arg+PGE(1) group, ischemic rats treated with both L-arg and PGE(1). Renal function and histology were assessed on days 2 and 7 postoperatively.
RESULTS: All rats, except control ones, showed a significant improvement of renal function towards normal on postoperative day 7. Serum creatinine and creatinine clearance were significantly better in L-arg+PGE(1) group compared to all other groups on day 7. With the exception of sham-operated and L-arg+PGE(1)-treated animals, all other groups showed significant increases in fractional excretion of sodium (FE(Na)) in response to renal ischemia-reperfusion. The severest tubular damage was determined in the kidneys of control rats. Rats treated with L-arg+PGE(1) had the least severe tubular damage.
CONCLUSION: The administration of either L-arg or PGE(1) attenuates both functional and structural consequences of renal warm ischemia. A near total protection might be achieved when both agents are administered concomitantly. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337910     DOI: 10.1159/000100425

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  6 in total

1.  Effect of the technique for assisting renal blood circulation on ischemic kidney in acute cardiorenal syndrome.

Authors:  Shigeru Hanada; Yoshiaki Takewa; Toshihide Mizuno; Tomonori Tsukiya; Yoshiyuki Taenaka; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2011-10-21       Impact factor: 1.731

Review 2.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

3.  How effective are alprostadil and hydrocortisone on reperfusion injury in kidney after distant organ ischemia?

Authors:  Ali Ebrahimi; Fereshteh Salimi; Mansour Safaei; Hamid Melali; Amir Hosein Davarpanah Jazi; Mehdi Nematbakhsh; Nematbakhsh Mokhtari; Hamidreza Rasooli
Journal:  J Res Med Sci       Date:  2013-09       Impact factor: 1.852

4.  Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy.

Authors:  Wei Wei; Xing-Rong An; Shi-Jie Jin; Xiao-Xue Li; Ming Xu
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

5.  Impact of preconditioning stem cells with all-trans retinoic acid signaling pathway on cisplatin-induced nephrotoxicity by down-regulation of TGFβ1, IL-6, and caspase-3 and up-regulation of HIF1α and VEGF.

Authors:  Mohsen Khedr; Nashwa Barakat; Ibrahem Mohey El-Deen; Faten Zahran
Journal:  Saudi J Biol Sci       Date:  2021-10-12       Impact factor: 4.219

6.  Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment.

Authors:  Muhammad Shareef Masoud; Sanam Saiqa Anwar; Muhammad Zeeshan Afzal; Azra Mehmood; Shaheen N Khan; Sheikh Riazuddin
Journal:  J Transl Med       Date:  2012-12-05       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.